Results 181 to 190 of about 45,444 (286)

Long‐Term Outcomes of Reduced‐Intensity Conditioning Hematopoietic Stem Cell Transplantation for Patients With Systemic Sclerosis With Impaired Cardiac Function

Arthritis &Rheumatology, Volume 78, Issue 6, Page 1294-1305, June 2026.
Objective High‐intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced systemic sclerosis (SSc). The role of reduced‐intensity conditioning (RIC) before AHSCT in this population remains unclear.
Yonatan Lean, Carrie Richardson, Anthony J. Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

Antinuclear Antibodies in Polycystic Ovary Syndrome: A Systematic Review of Observational Studies. [PDF]

Int J Mol Sci
Kwiatkowski J, Akpang N, Zaborowska L, Ludwin A.   +3 more
europepmc   +1 more source

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study

Arthritis &Rheumatology, Volume 78, Issue 6, Page 1258-1267, June 2026.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate to severe systemic lupus erythematosus (SLE) activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly
Susan Manzi, Ian N. Bruce, Eric F. Morand, Richard Furie, Yoshiya Tanaka, Kenneth C. Kalunian, Anca Askanase, Patricia Puzio, Emon Khan, Jenny Wissmar, Michael Song, Catharina Lindholm, for the TULIP‐SC investigators   +12 more
wiley   +1 more source

The Art of Interpreting Antinuclear Antibodies (ANAs) in Everyday Practice. [PDF]

J Clin Med
Kądziela M, Fijałkowska A, Kraska-Gacka M, Woźniacka A.   +3 more
europepmc   +1 more source

Antinuclear Antibodies Are Associated with an Increased Risk of Diffuse Large B-Cell Lymphoma. [PDF]

Cancers (Basel), 2023
Frost E, Hofmann JN, Huang WY, Parks CG, Frazer-Abel AA, Deane KD, Berndt SI.   +6 more
europepmc   +1 more source

Voclosporin‐induced gingival enlargement: A case report

Clinical Advances in Periodontics, Volume 16, Issue 2, Page 338-343, June 2026.
Abstract Background Drug‐influenced gingival enlargement (DIGE) is a recognized adverse effect of certain medications, particularly immunosuppressants like cyclosporin and tacrolimus. However, there have been no documented cases of DIGE associated with voclosporin, a newer calcineurin inhibitor used primarily to treat lupus nephritis.
Francesca Racca, Jessica M. Greco, Dimitris N. Tatakis   +2 more
wiley   +1 more source

Diagnostic Utility of Antibodies to Extractable Nuclear Antigens in the Absence of Positive Antinuclear Antibodies. [PDF]

Cureus
Huang J, Dargham BB, Luggen M.
europepmc   +1 more source

The Heart of the Thymus: A Rare Tale of Nonischemic Cardiomyopathy in the Absence of Myasthenia Gravis

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Thymomas are rare epithelial tumors of the anterior mediastinum known for their association with autoimmune and paraneoplastic syndromes, most notably myasthenia gravis (MG). Cardiomyopathy is an exceptionally rare paraneoplastic manifestation.
Manish Barman, Bassem Al Hariri, Tasneem Babiker, Mohamed Gadkarem, Joudi Alhariri, Ahmad Alharafsheh   +5 more
wiley   +1 more source

Binding of established antinuclear antibodies to neurons depends on tissue fixation and underlying autoantigens. [PDF]

Front Immunol
Li LY, Höltje M, Rasmussen HF, Halle L, Mayrhofer M, Blüthner M, Prüss H.   +6 more
europepmc   +1 more source

Increasing Prevalence of Antinuclear Antibodies in the United States. [PDF]

Arthritis Rheumatol, 2022
Dinse GE, Parks CG, Weinberg CR, Co CA, Wilkerson J, Zeldin DC, Chan EKL, Miller FW.   +7 more
europepmc   +1 more source